Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-02-14
2011-12-06
Gabel, Gail R (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007900, C435S007930, C436S522000, C436S526000, C436S536000, C436S017000, C436S018000, C436S175000, C436S176000, C436S177000, C436S179000, C436S815000, C424S009200
Reexamination Certificate
active
08071317
ABSTRACT:
Methods and reagents are disclosed for pretreating a sample suspected of containing a hydrophobic drug for conducting an assay method for detecting the hydrophobic drug. A combination is provided in a medium. The combination comprises (i) the sample, (ii) a releasing agent for releasing the hydrophobic drug and the metabolites from endogenous binding moieties, and (iii) a selective solubility agent that provides for substantially equal solubility of the hydrophobic drug and the metabolites in the medium. The selective solubility agent comprises a water miscible, non-volatile organic solvent and is present in the medium in a concentration sufficient to provide for substantially equal solubility of the hydrophobic drug and the metabolites in the medium. The medium, which may further comprise a hemolytic agent, is incubated under conditions for releasing the hydrophobic drug and the metabolites from endogenous binding moieties. For conducting an assay for the hydrophobic drug, the above pretreatment is performed and to the medium is added reagents for determining the presence and/or amount of the hydrophobic drug in the sample wherein the reagents comprise at least one antibody for the hydrophobic drug. The medium is examined for the presence of a complex comprising the hydrophobic drug and the antibody for the hydrophobic drug, the presence and/or amount of the complex indicating the presence and/or amount of the hydrophobic drug in the sample.
REFERENCES:
patent: 5135875 (1992-08-01), Meucci et al.
patent: 5340716 (1994-08-01), Ullman et al.
patent: 5565326 (1996-10-01), Daiss et al.
patent: 5650288 (1997-07-01), MacFarlane et al.
patent: 6171801 (2001-01-01), Staples et al.
patent: 6187547 (2001-02-01), Legay et al.
patent: 6190873 (2001-02-01), Davalian et al.
patent: 6225073 (2001-05-01), Alexander et al.
patent: 6777190 (2004-08-01), Buechler et al.
patent: 6790668 (2004-09-01), Ferreira et al.
patent: 6825000 (2004-11-01), Yokoi et al.
patent: 6887669 (2005-05-01), Staples et al.
patent: 7186518 (2007-03-01), Wang et al.
patent: 2005/0112778 (2005-05-01), Wang et al.
patent: 2006/0246518 (2006-11-01), Chen et al.
patent: 2007/0087396 (2007-04-01), Konrath et al.
patent: 2007/0122913 (2007-05-01), Tanaka et al.
patent: 2008/0311676 (2008-12-01), Brate et al.
patent: 0 471 295 (1992-02-01), None
patent: 2008/082974 (2008-07-01), None
patent: 2008/147982 (2008-12-01), None
Simamora P et al: “Solubilization of Rapamycin”, International Journal of Pharmaceutics, Elsevier BV, NL, vol. 213, No. 1-2, Feb. 1, 2001, pp. 25-29, XP002571642, ISSN: 0378-5173, DOI:DOI:10.1016/S0378-5173(00)00617-7.
Craig Alan
Posey Amy
Wei Tie Q.
Gabel Gail R
Leitereg Theodore J.
Siemens Healthcare Diagnostics Inc.
LandOfFree
Methods for detection of hydrophobic drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detection of hydrophobic drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detection of hydrophobic drugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4263500